Treatment pattern and outcomes of re-induction therapy prior to stem cell transplantation in patients with relapsed/refractory multiple myeloma in Germany

There are limited data guiding choice of re-induction therapies for patients with relapsed/refractory multiple myeloma (RRMM) prior to stem cell transplantation (SCT). We performed a retrospective medical chart review of 171 patients with RRMM in Germany who received re-induction therapy in second l...

Full description

Saved in:
Bibliographic Details
Main Authors: Sauer, Sandra (Author) , Engelhardt, Monika (Author) , Trautmann-Grill, Karolin (Author) , Kimmich, Christoph (Author) , Hänel, Mathias (Author) , Schmidt-Hieber, Martin (Author) , Salwender, Hans (Author) , Flossmann, Carmen (Author) , Heckmann, Hiltrud (Author) , Ertel, Franziska (Author) , Friederich, Andrea (Author) , Patel, Sachin (Author) , Thun, Barbara (Author) , Raab, Marc-Steffen (Author)
Format: Article (Journal)
Language:English
Published: 14 March 2024
In: Bone marrow transplantation
Year: 2024, Volume: 59, Issue: 6, Pages: 880-889
ISSN:1476-5365
DOI:10.1038/s41409-024-02208-3
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41409-024-02208-3
Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41409-024-02208-3
Get full text
Author Notes:Sandra Sauer, Monika Engelhardt, Karolin Trautmann-Grill, Christoph Kimmich, Mathias Hänel, Martin Schmidt-Hieber, Hans Salwender, Carmen Flossmann, Hiltrud Heckmann, Franziska Ertel, Andrea Friederich, Sachin Patel, Barbara Thun and Marc S. Raab

MARC

LEADER 00000caa a2200000 c 4500
001 1897329989
003 DE-627
005 20250118003027.0
007 cr uuu---uuuuu
008 240801s2024 xx |||||o 00| ||eng c
024 7 |a 10.1038/s41409-024-02208-3  |2 doi 
035 |a (DE-627)1897329989 
035 |a (DE-599)KXP1897329989 
035 |a (OCoLC)1475305261 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Sauer, Sandra  |d 1975-  |e VerfasserIn  |0 (DE-588)1060031140  |0 (DE-627)799171778  |0 (DE-576)416132855  |4 aut 
245 1 0 |a Treatment pattern and outcomes of re-induction therapy prior to stem cell transplantation in patients with relapsed/refractory multiple myeloma in Germany  |c Sandra Sauer, Monika Engelhardt, Karolin Trautmann-Grill, Christoph Kimmich, Mathias Hänel, Martin Schmidt-Hieber, Hans Salwender, Carmen Flossmann, Hiltrud Heckmann, Franziska Ertel, Andrea Friederich, Sachin Patel, Barbara Thun and Marc S. Raab 
264 1 |c 14 March 2024 
300 |b Illustrationen 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 01.08.2024 
520 |a There are limited data guiding choice of re-induction therapies for patients with relapsed/refractory multiple myeloma (RRMM) prior to stem cell transplantation (SCT). We performed a retrospective medical chart review of 171 patients with RRMM in Germany who received re-induction therapy in second line (78%; n = 134) or third line (22%; n = 37) prior to re-SCT. Index therapy was defined as first completed re-induction therapy for planned myeloablative conditioning and SCT in second/third line within the eligibility period (1/2016-12/2019). Most common pre-index first line and maintenance therapy used were bortezomib-based combinations (91%; n = 155/171) and lenalidomide (55%; n = 29/53), respectively. Median duration of index therapy line was 9 months; carfilzomib-based combinations were the most widely used in second/third line re-induction therapy (49%; n = 83/171), followed by daratumumab-based combinations (21%; n = 36/171). Overall response rates in second/third line were 87% after re-induction and 96% after SCT; median time to next treatment line after start of index therapy was 31 months; median progression-free survival (PFS) was 29 months; and median overall survival after index date was not reached. Based on these data, re-induction therapy with salvage SCT appears to be beneficial in selected patients with RRMM in clinical practice in Germany, translating into deep responses, long PFS and prolonged time to next treatment. 
650 4 |a Cancer therapy 
650 4 |a Combination drug therapy 
700 1 |8 1\p  |a Engelhardt, Monika  |d 1966-  |e VerfasserIn  |0 (DE-588)113263538  |0 (DE-627)390016233  |0 (DE-576)169992101  |4 aut 
700 1 |8 2\p  |a Trautmann-Grill, Karolin  |e VerfasserIn  |0 (DE-588)1267849436  |0 (DE-627)1816403342  |4 aut 
700 1 |a Kimmich, Christoph  |e VerfasserIn  |4 aut 
700 1 |a Hänel, Mathias  |d 1964-  |e VerfasserIn  |0 (DE-588)17362295X  |0 (DE-627)698532414  |0 (DE-576)134465970  |4 aut 
700 1 |a Schmidt-Hieber, Martin  |e VerfasserIn  |4 aut 
700 1 |8 3\p  |a Salwender, Hans  |e VerfasserIn  |0 (DE-588)1114928666  |0 (DE-627)869399993  |0 (DE-576)477578233  |4 aut 
700 1 |a Flossmann, Carmen  |e VerfasserIn  |4 aut 
700 1 |a Heckmann, Hiltrud  |e VerfasserIn  |4 aut 
700 1 |a Ertel, Franziska  |e VerfasserIn  |4 aut 
700 1 |a Friederich, Andrea  |e VerfasserIn  |4 aut 
700 1 |a Patel, Sachin  |e VerfasserIn  |4 aut 
700 1 |a Thun, Barbara  |e VerfasserIn  |4 aut 
700 1 |a Raab, Marc-Steffen  |d 1973-  |e VerfasserIn  |0 (DE-588)124052460  |0 (DE-627)706520998  |0 (DE-576)293998027  |4 aut 
773 0 8 |i Enthalten in  |t Bone marrow transplantation  |d London : Springer Nature, 1997  |g 59(2024), 6, Seite 880-889  |h Online-Ressource  |w (DE-627)320433366  |w (DE-600)2004030-1  |w (DE-576)091012996  |x 1476-5365  |7 nnas  |a Treatment pattern and outcomes of re-induction therapy prior to stem cell transplantation in patients with relapsed/refractory multiple myeloma in Germany 
773 1 8 |g volume:59  |g year:2024  |g number:6  |g pages:880-889  |g extent:10  |a Treatment pattern and outcomes of re-induction therapy prior to stem cell transplantation in patients with relapsed/refractory multiple myeloma in Germany 
856 4 0 |u https://doi.org/10.1038/s41409-024-02208-3  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/s41409-024-02208-3  |x Verlag  |z kostenfrei  |3 Volltext 
883 |8 1\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 2\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 3\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
951 |a AR 
992 |a 20240801 
993 |a Article 
994 |a 2024 
998 |g 124052460  |a Raab, Marc-Steffen  |m 124052460:Raab, Marc-Steffen  |d 910000  |d 910100  |e 910000PR124052460  |e 910100PR124052460  |k 0/910000/  |k 1/910000/910100/  |p 14  |y j 
998 |g 1060031140  |a Sauer, Sandra  |m 1060031140:Sauer, Sandra  |d 910000  |d 910100  |e 910000PS1060031140  |e 910100PS1060031140  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1897329989  |e 4561494847 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1897329989","note":["Gesehen am 01.08.2024"],"name":{"displayForm":["Sandra Sauer, Monika Engelhardt, Karolin Trautmann-Grill, Christoph Kimmich, Mathias Hänel, Martin Schmidt-Hieber, Hans Salwender, Carmen Flossmann, Hiltrud Heckmann, Franziska Ertel, Andrea Friederich, Sachin Patel, Barbara Thun and Marc S. Raab"]},"origin":[{"dateIssuedDisp":"14 March 2024","dateIssuedKey":"2024"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1897329989"],"doi":["10.1038/s41409-024-02208-3"]},"language":["eng"],"relHost":[{"note":["Gesehen am 17.01.25"],"pubHistory":["Nachgewiesen 19.1997 -"],"recId":"320433366","disp":"Treatment pattern and outcomes of re-induction therapy prior to stem cell transplantation in patients with relapsed/refractory multiple myeloma in GermanyBone marrow transplantation","part":{"extent":"10","year":"2024","issue":"6","volume":"59","text":"59(2024), 6, Seite 880-889","pages":"880-889"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Bone marrow transplantation","title":"Bone marrow transplantation"}],"id":{"eki":["320433366"],"zdb":["2004030-1"],"issn":["1476-5365"]},"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"1997","publisher":"Springer Nature ; Macmillan ; Nature Publishing Group","publisherPlace":"London ; Basingstoke ; London","dateIssuedDisp":"1997-"}]}],"person":[{"given":"Sandra","display":"Sauer, Sandra","family":"Sauer","role":"aut"},{"family":"Engelhardt","display":"Engelhardt, Monika","given":"Monika","role":"aut"},{"role":"aut","given":"Karolin","family":"Trautmann-Grill","display":"Trautmann-Grill, Karolin"},{"role":"aut","family":"Kimmich","display":"Kimmich, Christoph","given":"Christoph"},{"role":"aut","display":"Hänel, Mathias","family":"Hänel","given":"Mathias"},{"role":"aut","given":"Martin","family":"Schmidt-Hieber","display":"Schmidt-Hieber, Martin"},{"role":"aut","display":"Salwender, Hans","family":"Salwender","given":"Hans"},{"role":"aut","display":"Flossmann, Carmen","family":"Flossmann","given":"Carmen"},{"family":"Heckmann","display":"Heckmann, Hiltrud","given":"Hiltrud","role":"aut"},{"given":"Franziska","family":"Ertel","display":"Ertel, Franziska","role":"aut"},{"display":"Friederich, Andrea","family":"Friederich","given":"Andrea","role":"aut"},{"family":"Patel","display":"Patel, Sachin","given":"Sachin","role":"aut"},{"role":"aut","display":"Thun, Barbara","family":"Thun","given":"Barbara"},{"role":"aut","given":"Marc-Steffen","display":"Raab, Marc-Steffen","family":"Raab"}],"title":[{"title":"Treatment pattern and outcomes of re-induction therapy prior to stem cell transplantation in patients with relapsed/refractory multiple myeloma in Germany","title_sort":"Treatment pattern and outcomes of re-induction therapy prior to stem cell transplantation in patients with relapsed/refractory multiple myeloma in Germany"}],"physDesc":[{"extent":"10 S.","noteIll":"Illustrationen"}]} 
SRT |a SAUERSANDRTREATMENTP1420